High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5860-5866

  Sun, Hee Kim ^a   Castro, Francisco ^a   Paterson, Yvonne ^b   Gravekamp, Claudia ^a,c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CANCER VACCINE; LISTERIA MONOCYTOGENES VACCINE; LISTERIOLYSIN O; MELANOMA ANTIGEN; MELANOMA ANTIGEN B[311-660]; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER GROWTH; CANCER IMMUNIZATION; CANCER MODEL; CANCER PREVENTION; CD8+ T LYMPHOCYTE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; SPLEEN; TUMOR CELL;

ANIMALS; BACTERIAL TOXINS; BREAST NEOPLASMS; CALCIUM; CANCER VACCINES; CELL LINE, TUMOR; CELL SURVIVAL; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNIZATION; LISTERIA MONOCYTOGENES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICROSCOPY, ELECTRON; NADPH OXIDASE; NEOPLASM METASTASIS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 67650996837     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4855     Document Type: Article

References (33)

1. Althuis MD, Singh S. Global trends in breast cancer incidence and mortality. 1973-1997. Int J Epidemiol 2005;34:405-12.
2. Berkowitz N, Gupta S, Silberman G. Estimates of the lifetime direct costs of treatment for metastatic breast cancer. Value Health 2000;3:23-30.
3. Scart H, Cantin J, Levin M. Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ 2002;167:145-55.
4. Kurtz JE, Dufour P. Strategies for improving quality of life in older patients with metastatic breast cancer. Drugs Aging 2002;19:605-22.
5. Alberg AJ, Singh S. Epidemiology of breast cancer in older women: implications for future health care. Drugs Aging 2001;18:761-2.
6. Sypniewska RK, Hoflack L, Tarango M, et al. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy. BCRT 2005;91:19-28.
7. Gravekamp C, Leal B, Denny A, et al. In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1. Cancer Immunol Immunother 2008;57:1067-77.
8. Park JW, Kwon TK, Kim IH, et al. A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol 2002;79:79-86.
9. Paterson Y, Maciag P. Listeria-based vaccines for cancer treatment. Curr Opin Mol Ther 2005;7:454-60.
10. Dussurget O, Pizarro-Cerda J, Cossart P. Molecular determinants of Listeria monocytogenes virulence. Ann Rev 2004;58:587-10.
11. Gedde MM, Higgins DE, Tilney LG, Portnoy DA. Role of Lysteriolysn O in cell-to-cell spread of Listeria monocytogenes. Infect Immun 2000;68:999-1003.
12. Paterson Y, Ikonomidis G. Recombinant Listeria monocytogenes cancer vaccines. Curr Opin Immunol 1996;8:664-9.
13. Singh R, Domineicki ME, Jaffee EM, Paterson Y. Fusion of Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J Immunol 2005;175:3663-73.
14. Gaillard JL, Berche PP, Sansonetti P. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect Immun 1986;52:50-5.
15. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hymolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988;167:1459-71.
16. Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. British Journal of Cancer 2008;99:741-9.
17. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. Two Listeria monoytogenes vaccine vectors that express different molecular forms of human papillomavirus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001;167:6471-9.
18. Pan ZK, Okonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumor antigen protects mice against lethal tumor challenge and causes regression of established tumors. Nature Med 1995;1:471-7.
19. Chambers RS, Johnston SA. High-level generation of polyclonal antibodies by genetic immunization. Nature Biotechnol 2003;21:1088-92.
20. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992;152:99.
21. Pease DC. Histological techniques for electron microscopy. New York and London: Academic Press; 1964.
22. Stenberg PE, Shuman MA, Levine SP, Bainton DF. Redistribution of α-granules and their contents in thrombin-stimulated platelets. J Biol Chem 1984;98:748-60.
23. Lancellotti M, Brocchi M, da Silvedeira WD. Bacteria-induced apoptosis: an approach to bacterial pathogenesis. Braz J Morphol Sci 2006;23:75-86.
24. North BM. Murine Listeriosis as a model of antimicrobial defense. Immunol Rev 1997;158:27-36.
25. Rogers HW, Unanue ER. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 1993;61:5090-6.
26. Unanue ER. Inter-relationships among macrophages, natural killer cells, and neutrophils in early stages of Listeria resistance. Curr Opin Immunol 1997;1:25-43.
27. Wadsworth S, Goldfine H. Mobilization of proteinase C in macrophages induced by Listeria monocytogenes affects its internalization and escape from the phagosome. Infect Immun 2002;70:4650-60.
28. Schnupf P, Portnoy DA, Decatur AL. Phosphorylation, ubiquitination and degradation of Listeriolysin O in mammalian cells: role of the PEST-like sequence. Cell Microbiol 2006;8:353-64.
29. Abelman HW. In: Cancer as I see it. New York: Philosophical Library, Inc.; 1951.
30. Yu YA, Shabahang S, Timiryasova TM, et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nature Biotechn 2004;22:313-20.
31. Stritzker J, Pilgrim S, Szalay AA, Goebel W. Prodrug converting enzyme gene delivery by L. monocytogenes. BMC Cancer 2008. doi: 10.1186/1471-2407-8-94.
32. Gajewski TF, Meng Y, Harlin H. Immune suppression in tumor microenvironment. J Immunother 2006;29:233-40.
33. Rothman J. The first use of Live Listeria cancer vaccine in man. Abstract 225. AACR Conference, San Diego, CA. April 12-16, 2008.